People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Emit Imaging, Inc. | — | Biotechnology | Series A | $13.5M | $33.5M | 2024 |
| Sentonix, Inc. | — | Pharmaceuticals | Series A | $6.5M | $30.2M | 2024 |
Jack Hoppin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jack Hoppin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William U. Parfet | 1 | 5 |
| John Beaver | 1 | 4 |
| Kenan Turnacioglu | 1 | 4 |
| Jack U. Hoppin | 1 | 2 |
| William Parfet | 1 | 2 |
| Christian Lackas | 1 | 2 |
| Matthew Silva | 1 | 1 |
| Christian U. Lackas | 1 | 1 |
| Karl Schmidt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.